tessellon products
|
|
William P. Cacheris
 William P. Cacheris, Ph.D., M.B.A., has over 25 years experience in the pharmaceutical industry with more than 15 years' experience in the pharmaceutical consulting industry specializing on global epidemiology, product and market assessment and forecasting. Bill has conducted more than 250 product forecasts for the U.S. Europe and Japan built from epidemiology, patient segmentation, disease treatment patterns, market trends, product positioning, and future market dynamics that report and summarize forecasted products sales. During the 10+ years in forecasting pharmaceutical markets at the Mattson Jack Group, Bill demonstrated success in multiple therapeutic areas. He has direct design and management involvement in broad epidemiology products and projects, many specific for oncology. In oncology, Bill's efforts with global oncology epidemiology data sources and methodology have produced patient numbers that are essential in business planning activities for pharmaceutical companies.
Cara Spencer
 Cara Spencer has over nine years of experience in employing mathematical modeling for patient epidemiology and market analysis. Also hailing from the Mattson Jack Group, she has focused on techniques used in epidemiology, patient flow, curve fitting, and survival curve analysis as well as spreadsheet model design to increase user-friendliness. Cara has experience in mathematical quantification of market analytics and market modeling in multiple therapeutic areas including diabetes, HIV, HCV, oncology, and rare diseases. Cara earned a B.S. in Mathematics at Truman State University.
Anna Tucker
 Anna Tucker has worked in the pharmaceutical industry or pharmaceutical consulting industry for six years. A true industry insider, Anna's experience at the Mattson Jack Group and Stiefel Laboratories has given her the experience needed for forecasting and analyzing multiple therapeutic areas, including significant knowledge in dermatology and oncology. Anna has focused on market analytics and mathematical modeling in both new product and in-line forecasting. In addition, Anna has considerable skill utilizing database programs to combine, analyze, and query large datasets. Anna earned an M.S. in applied mathematics at Iowa State University.
Russ Belden
Russ Belden is the Founder and Managing Partner of Bridge Consulting specializing in optimizing commercial strategy for the biotech industry. With over 25 years of marketing and product development experience, Russ has extensive experience in oncology, cardiovascular, pulmonary and metabolic diseases. He served as a leader of the BioOncology business unit and sales director of hematology at Genentech over his 16 years with the organization. Russ earned a B.S. in Pharmacy from SUNY-Buffalo.
|
